Literature DB >> 24596200

MYC, MAX, and small cell lung cancer.

Charles M Rudin1, J T Poirier.   

Abstract

SUMMARY: In this issue of Cancer Discovery, Romero and colleagues identify somatic mutations and deletions of MAX, and also define what seem to be mutually exclusive alterations in MYC family members and other MYC-associated factors in small cell lung cancer. Taken together, these data highlight the importance of MYC signaling in small cell lung cancer and suggest possible avenues for therapeutic intervention.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24596200     DOI： 10.1158/2159-8290.CD-14-0069

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  8 in total

1.  Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.

Authors:  Brian A Walker; Konstantinos Mavrommatis; Christopher P Wardell; T Cody Ashby; Michael Bauer; Faith E Davies; Adam Rosenthal; Hongwei Wang; Pingping Qu; Antje Hoering; Mehmet Samur; Fadi Towfic; Maria Ortiz; Erin Flynt; Zhinuan Yu; Zhihong Yang; Dan Rozelle; John Obenauer; Matthew Trotter; Daniel Auclair; Jonathan Keats; Niccolo Bolli; Mariateresa Fulciniti; Raphael Szalat; Philippe Moreau; Brian Durie; A Keith Stewart; Hartmut Goldschmidt; Marc S Raab; Hermann Einsele; Pieter Sonneveld; Jesus San Miguel; Sagar Lonial; Graham H Jackson; Kenneth C Anderson; Herve Avet-Loiseau; Nikhil Munshi; Anjan Thakurta; Gareth J Morgan
Journal:  Blood       Date:  2018-06-08       Impact factor: 22.113

Review 2.  Small cell lung cancer: will recent progress lead to improved outcomes?

Authors:  M Catherine Pietanza; Lauren Averett Byers; John D Minna; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2015-05-15       Impact factor: 12.531

3.  Biology and evolution of poorly differentiated neuroendocrine tumors.

Authors:  David S Rickman; Himisha Beltran; Francesca Demichelis; Mark A Rubin
Journal:  Nat Med       Date:  2017-06-06       Impact factor: 53.440

Review 4.  The Genomics of Prostate Cancer: A Historic Perspective.

Authors:  Mark A Rubin; Francesca Demichelis
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

5.  N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.

Authors:  Adeline Berger; Nicholas J Brady; Rohan Bareja; Brian Robinson; Vincenza Conteduca; Michael A Augello; Loredana Puca; Adnan Ahmed; Etienne Dardenne; Xiaodong Lu; Inah Hwang; Alyssa M Bagadion; Andrea Sboner; Olivier Elemento; Jihye Paik; Jindan Yu; Christopher E Barbieri; Noah Dephoure; Himisha Beltran; David S Rickman
Journal:  J Clin Invest       Date:  2019-07-01       Impact factor: 14.808

6.  Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer.

Authors:  Xiaoke Liu; Yong Xu; Zongguo Pang; Fuchun Guo; Qing Qin; Tao Yin; Yaxiong Sang; Chengjun Feng; Xiaoyu Li; Li Jiang; Pei Shu; Yongsheng Wang
Journal:  J Hematol Oncol       Date:  2015-06-11       Impact factor: 17.388

7.  Discovery of cell-type specific DNA motif grammar in cis-regulatory elements using random Forest.

Authors:  Xin Wang; Peijie Lin; Joshua W K Ho
Journal:  BMC Genomics       Date:  2018-01-19       Impact factor: 3.969

8.  Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase.

Authors:  Tao Qin; Ningning Zhou; Yin-Duo Zeng; Xiaoxiao Dinglin; Yuanyuan Zhao; Huai Liu; Likun Chen
Journal:  Onco Targets Ther       Date:  2016-03-01       Impact factor: 4.147
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.